The American Society of Clinical Oncology annual meeting, beginning this week in Atlanta, offers about as many sessions related to pharmacogenomics and targeted therapies as the 2005 meeting, with the exception of the developmental therapeutics track, which has approximately doubled the number of sessions in these areas to a total of six.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.